The Norwegian Radium Hospital, The Research Building
CCB congratulates Group leader Guro E. Lind with a prestigious 4-year career grant from the South-Eastern Norway Regional Health Authority (Helse Sør-Øst).
CCB congratulates Guro Elisabeth Lind with this one-year PI position for 2013.
In a recent issue of EMBO Reports (published online 16 Nov), PhD student Angela Oppelt (photo) and her colleagues in Jørgen Wesche's project group at the Institute for Cancer Research present a novel regulator of cell migration.
A study carried out at Edward Leithe’s project group at Centre for Cancer Biomedicine and Department of Cancer Prevention has been awarded a prize for Excellent Research Article by the Oslo University Hospital. The prize was presented on Friday 26th October and carries an award of 50,000 kr.
Results from colorectal cancer research at CCB, Department of Cancer Prevention, Institute for Cancer Research and Department of Gastrointestinal Surgery have been highlighted from recent cancer literature as “Breaking Advances” in the AACR journal Cancer Research, October 15th, 2012.
The Norwegian newspaper Aftenposten published on September 4th, 2012 an article about health issues related to nanoparticles.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the month". For the month of August 2012, this honor goes to CCB's Principal Investigator Ragnhild A. Lothe from the Department of Cancer Prevention at the Institute for Cancer Research, Oslo University Hospital.
Erlend B. Smeland from the Department of Immunology at the Norwegian Radium Hospital, co-authors an article published online in Nature on August 12, entitled “Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics"
In a new study now published in Oncogene (journal impact factor 6.4), Sascha Pust and coworkers from the Centre for Cancer Biomedicine show that flotillins stabilize ErbB2 at the plasma membrane.
A study by PhD student Ane Hansen Kjenseth and colleagues in Edgar Rivedal’s group at CCB has identified a novel mechanism for regulation of intercellular communication. The article was published in the May 4 issue of Journal of Biological Chemistry, and was featured on the cover of the journal.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the month". For the month of April 2012, this honor goes to CCB's Principal Investigator Kirsten Sandvig from the Department of Biochemistry at the Institute for Cancer Research, Oslo University Hospital.
The Programme for Publicly-initiated Clinical Cancer Studies provides support to research projects that will increase understanding and thereby enhance the basis for effective decision-making within cancer treatment and care.
The program has recently decided to distribute a sum amounting to about 65 MNOK among three projects, all of which are led by scientists from the Norwegian Radium Hospital: Mælandsmo, Loge, and Myklebost, and all of which are involving CCB scientists or clinicians associated with CCB.
Alicia Llorente and Kirsten Sandvig, Department of Biochemistry, Institute for Cancer Research and Centre for Cancer Biomedicine, have recently published a proteomic analysis of microvesicles released from a human prostate cancer cell line in the journal Molecular and Cellular Proteomics (impact factor 8.4).
New biomarkers can make hunting for prostate cancer more accurate.
Researchers at the Centre for Cancer Biomedicine, Oslo University Hospital, have developed a gene signature that is suitable to be developed into a prognostic test for patients with stage II colorectal cancer.
The Norwegian Biochemical Society arranged its 48th Contact Meeting at Storefjell, January 19th-22nd, 2012, and high quality science was presented both in lectures and as posters.
In the Dec 22 2011 issue of Nature Cell Biology, Tor Erik Rusten and Harald Stenmark from the Institute for Cancer Research and the Centre for Cancer Biomedicine review recent findings that implicate the endosomal sorting complex required for transport (ESCRT) machinery in developmental processes.